APUS
Apimeds Pharmaceuticals US, Inc.Company with tickers: APUS
CIK
1894525
CUSIP
03771D102
Shares Outstanding
12,575,983
13F Activity (30d)
4 filings
4 filers
Price
$1.44
Market Cap
$18.86M
P/E Ratio
-2.62
EPS (Diluted)
$-0.55
52W High
$40.31
52W Low
$1.24
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $12,185,694 | USD | 2026-03-31 | 10-Q | 2026-05-26 |
| Research & Development | $901,144 | USD | 2026-03-31 | 10-Q | 2026-05-26 |
| Operating Income | $-12,185,694 | USD | 2026-03-31 | 10-Q | 2026-05-26 |
| Net Income | $-35,059,852 | USD | 2026-03-31 | 10-Q | 2026-05-26 |
| EPS (Basic) | $-2.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-26 |
| EPS (Diluted) | $-2.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-26 |